{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T06:24:50Z","timestamp":1762323890890},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,11,30]],"date-time":"2015-11-30T00:00:00Z","timestamp":1448841600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Drug Metab Pharmacokinet"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s13318-015-0311-4","type":"journal-article","created":{"date-parts":[[2015,11,30]],"date-time":"2015-11-30T01:01:53Z","timestamp":1448845313000},"page":"807-818","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Enhancement of Dissolution Rate and Intestinal Stability of Clopidogrel Hydrogen Sulfate"],"prefix":"10.1007","volume":"41","author":[{"given":"Dina E.","family":"Bali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed A.","family":"Osman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gamal M.","family":"El Maghraby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,11,30]]},"reference":[{"key":"311_CR1","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.2042-7158.2011.01434.x","volume":"64","author":"MA Lassoued","year":"2012","unstructured":"Lassoued MA, Sfar S, Bouraoui A, Khemiss F. Absorption enhancement studies of clopidogrel hydrogen sulphate in rat everted gut sacs. J Pharm Pharmacol. 2012;64:541\u201352.","journal-title":"J Pharm Pharmacol."},{"key":"311_CR2","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1517\/17425255.3.4.621","volume":"3","author":"KA Fox","year":"2007","unstructured":"Fox KA, Chelliah R. Clopidogrel: an updated and comprehensive review. Expert Opin Drug Metab Toxicol. 2007;3:621\u201331.","journal-title":"Expert Opin Drug Metab Toxicol."},{"key":"311_CR3","unstructured":"European Medicines agency Evaluation of medicines for human use. Doc. Ref EMEA\/661461\/2009."},{"key":"311_CR4","first-page":"376","volume":"57","author":"V Zupancic","year":"2010","unstructured":"Zupancic V, Smrkolj M, Benkic P, Simonic I, Plevnik M, Ritlop G, Kristl A, Vrecer F. Preformulation investigation of some clopidogrel addition salts. Acta Chim Slov. 2010;57:376\u201385.","journal-title":"Acta Chim Slov"},{"issue":"08","key":"311_CR5","first-page":"217","volume":"01","author":"SK Singh","year":"2011","unstructured":"Singh SK, Som S, Shankhwar U. Formulation and optimization of solid dispersion of Clopidogrel with PEG 6000. J Appl Pharm Sci. 2011;01(08):217\u201326.","journal-title":"J Appl Pharm Sci."},{"issue":"1","key":"311_CR6","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nm.2281","volume":"17","author":"HJ Bouman","year":"2011","unstructured":"Bouman HJ, Sch\u00f6mig E, Werkum JWV, Velder J, Hackeng CM, Hirschh\u00e4user C, Waldmann C, Schmalz GH, Berg JMT, Taubert D. Paraoxonase-1 is a major determinant of clopidogrel efficacy. Nat Med. 2011;17(1):110\u20136.","journal-title":"Nat Med."},{"key":"311_CR7","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1128\/AAC.42.10.2602","volume":"42","author":"K Stoeckel","year":"1998","unstructured":"Stoeckel K, Hofheinz W, Laneury JP, Duchene P, Shedlofsky S, Blouin RA. Stability of cephalosporin prodrug esters in human intestinal juice: implications for oral bioavailability. Antimicrob Agents Chemother. 1998;42:2602\u20136.","journal-title":"Antimicrob Agents Chemother"},{"key":"311_CR8","first-page":"1089","volume":"35","author":"K Masaki","year":"2007","unstructured":"Masaki K, Hashimoto M, Imai T. Intestinal first-pass metabolism via carboxylesterase in rat jejunum and ileum. J Pharmacol Exp Ther. 2007;35:1089\u201395.","journal-title":"J Pharmacol Exp Ther"},{"key":"311_CR9","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.ejpb.2011.11.011","volume":"80","author":"AS Borde","year":"2012","unstructured":"Borde AS, Karlsson EM, Andersson K, Bjorhall K, Lennernas H, Abrahamsson B. Assessment of enzymatic prodrug stability in human, dog and simulated intestinal fluids. Eur J Pharm Biopharm. 2012;80:630\u20137.","journal-title":"Eur J Pharm Biopharm"},{"issue":"9","key":"311_CR10","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1002\/jps.23182","volume":"101","author":"K Ohura","year":"2012","unstructured":"Ohura K, Soejima T, Nogata R, Adachi Y, Ninomiya S, ImAai T. Effect of intestinal first-pass hydrolysis on the oral bioavailability of an ester prodrug of fexofenadine. J Pharm Sci. 2012;101(9):3264\u201374.","journal-title":"J Pharm Sci"},{"key":"311_CR11","unstructured":"Validation of analytical procedures: methodology. ICH Harmonized Tripartite Guidline. 1996."},{"key":"311_CR12","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.2042-7158.1975.tb09378.x","volume":"27","author":"KA Khan","year":"1975","unstructured":"Khan KA. The concept of dissolution efficiency. J Pharm Pharmacol. 1975;27:48\u20139.","journal-title":"J Pharm Pharmacol"},{"key":"311_CR13","first-page":"193","volume":"54","author":"V Koradia","year":"2004","unstructured":"Koradia V, Chawla G, Bansal AK. Qualitative and quantitative analysis of clopidogrel bisulphate polymorphs. Acta Pharm. 2004;54:193\u2013204.","journal-title":"Acta Pharm."},{"issue":"4","key":"311_CR14","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1208\/s12249-012-9868-2","volume":"13","author":"JDO Eloy","year":"2012","unstructured":"Eloy JDO, Saraiva J, Albuquerque SD, Marchetti JM. Solid dispersion of ursolic acid in gelucire 50\/13: a strategy to enhance drug release and trypanocidal activity. AAPS PharmSciTech. 2012;13(4):1436\u201345.","journal-title":"AAPS PharmSciTech."},{"key":"311_CR15","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.ijpharm.2014.12.037","volume":"478","author":"SA El-Gizawy","year":"2015","unstructured":"El-Gizawy SA, Osman MA, Arafa MF, El Maghraby GM. Aerosil as a novel co-crystal co-former for improving the dissolution rate of hydrochlorothiazide. Int J Pharm. 2015;478:773\u20138.","journal-title":"Int J Pharm"},{"issue":"9","key":"311_CR16","first-page":"1","volume":"1","author":"CP Azubuike","year":"2012","unstructured":"Azubuike CP, Okhamafe AO. Physicochemical, spectroscopic and thermal properties of microcrystalline cellulose derived from corn cobs. Int J Recycl Org Waste Agric. 2012;1(9):1\u20137.","journal-title":"Int J Recycl Org Waste Agric."},{"key":"311_CR17","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3797\/scipharm.1101-22","volume":"79","author":"M El-Badry","year":"2011","unstructured":"El-Badry M. Physicochemical characterization and dissolution properties of meloxicam-gelucire 50\/13 binary systems. Sci Pharm. 2011;79:375\u201386.","journal-title":"Sci Pharm."},{"key":"311_CR18","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jsps.2013.01.011","volume":"22","author":"MA Ibrahim","year":"2014","unstructured":"Ibrahim MA, El-Badry M. Formulation of immediate release pellets containing famotidine solid dispersions. Saudi Pharm J. 2014;22:149\u201356.","journal-title":"Saudi Pharm J."},{"issue":"6","key":"311_CR19","first-page":"73","volume":"5","author":"B Rashmika","year":"2013","unstructured":"Rashmika B, Veena V, Kachhwaha S, Bhikshapathi DVRN. Formulation development and in vivo evaluation of fexofenadine HCl solid dispersions by spray drying technique. Der Pharm Lett. 2013;5(6):73\u201382.","journal-title":"Der Pharm Lett"},{"issue":"3","key":"311_CR20","first-page":"157","volume":"5","author":"PD Maheswari","year":"2014","unstructured":"Maheswari PD, Rambhau D, Narasu ML. Development of valsartan controlled release formulations from spray dried powder by micellar solubilization technique. Inter J Adv Pharm Res. 2014;5(3):157\u201368.","journal-title":"Inter J Adv Pharm Res."},{"key":"311_CR21","first-page":"92","volume":"60","author":"LM Rus","year":"2012","unstructured":"Rus LM, Tomuta I, Iuga C, Maier C, Kacso I, Borodi G, Bratu I, Bojita M. Compatability studies of indapamide\/pharmaceutical excipients used in tablet preformulation. Farmacia. 2012;60:92\u2013101.","journal-title":"Farmacia."},{"issue":"4","key":"311_CR22","first-page":"1561","volume":"5","author":"L Pachuau","year":"2013","unstructured":"Pachuau L, Malsawmtluangi C, Nath NK, Ramdinsangi H, Vanlalfakawma DC, Tripathi SK. Physicochemical and functional characterization of microcrystalline cellulose from bamboo (Dendrocalamus longispathus). Inter J Pharm Tech Res. 2013;5(4):1561\u201371.","journal-title":"Inter J Pharm Tech Res."},{"issue":"8","key":"311_CR23","first-page":"2007","volume":"3","author":"S Pimple","year":"2014","unstructured":"Pimple S, Maurya P, Joshi A, Jain A, Gurjar M, Shah M. Formulation and in vitro evaluation of immediate release tablets containing antiplatelet drug: clopidogrel. World J Pharm Pharm Sci. 2014;3(8):2007\u201319.","journal-title":"World J Pharm Pharm Sci."},{"key":"311_CR24","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3797\/scipharm.0901-08","volume":"77","author":"GM EL Maghraby","year":"2009","unstructured":"EL Maghraby GM, Alomrani AH. Synergistic enhancement of itraconazole dissolution by ternary system formation with pluronic F68 and hydroxypropylmethylcellulose. Sci Pharm. 2009;77:401\u201317.","journal-title":"Sci Pharm"},{"issue":"2","key":"311_CR25","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1023\/B:PHAM.0000016235.32639.23","volume":"21","author":"RG Strickley","year":"2004","unstructured":"Strickley RG. Solubilizing excipients in oral and injectable formulations. Pharm Res. 2004;21(2):201\u201330.","journal-title":"Pharm Res"},{"key":"311_CR26","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.carbpol.2014.08.034","volume":"114","author":"DW Kim","year":"2014","unstructured":"Kim DW, Kwon MS, Yousaf AM, Balakrishnan P, Park JH, Kim DS, Lee BJ, Park YJ, Yong CS, Kim JO, Choia HG. Comparison of a solid SMEDDS and solid dispersion for enhanced stability and bioavailability of clopidogrel napadisilate. Carbohydr Polym. 2014;114:365\u201374.","journal-title":"Carbohydr Polym."},{"key":"311_CR27","first-page":"588","volume":"6","author":"P Patel","year":"2014","unstructured":"Patel P, Mehta T, Panchal S. Preparation, evaluation and comparison of lipid based drug delivery systems of tacrolimus. Int J Pharm Pharm Sci. 2014;6:588\u201391.","journal-title":"Int J Pharm Pharm Sci."},{"issue":"2","key":"311_CR28","first-page":"83","volume":"3","author":"N Patel","year":"2012","unstructured":"Patel N, Dalrymple DM, Serajuddin ATM. Development of solid SEDDS, III: application of Acconon\u00ae C-50 and Gelucire\u00ae 50\/13 as both solidifying and emulsifying agents for medium chain triglycerides. J Excip Food Chem. 2012;3(2):83\u201392.","journal-title":"J Excip Food Chem."},{"key":"311_CR29","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1124\/jpet.107.127027","volume":"323","author":"MA Schiel","year":"2007","unstructured":"Schiel MA, Green SL, Davis WI, Sanghani PC, Bosron WF, Sanghani SP. Expression and characterization of a human carboxylesterase 2 splice variant. J Pharmacol Exp Ther. 2007;323:94\u2013101.","journal-title":"J Pharmacol Exp Ther"},{"key":"311_CR30","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.lfs.2007.07.026","volume":"81","author":"M Taketani","year":"2007","unstructured":"Taketani M, Shii M, Ohura K, Ninomiya S, Imai T. Carboxylesterase in the liver and small intestine of experimental animals and human. Life Sci. 2007;81:924\u201332.","journal-title":"Life Sci"},{"key":"311_CR31","first-page":"1","volume":"9","author":"C Zhang","year":"2014","unstructured":"Zhang C, Xu Y, Zhong Q, Li X, Gao P, Feng C, Chu Q, Chen Y, Liu D. In vitro evaluation of the inhibitory potential of pharmaceutical excipients on human carboxylesterase 1A and 2. Plos one. 2014;9:1\u20138.","journal-title":"Plos one."},{"key":"311_CR32","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ijpharm.2006.01.050","volume":"317","author":"GE Granero","year":"2006","unstructured":"Granero GE, Amidon GL. Stability of valacyclovir: implications for its oral bioavailability. Int J Pharm. 2006;317:14\u20138.","journal-title":"Int J Pharm"},{"key":"311_CR33","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/bdd.364","volume":"24","author":"D Werdenberga","year":"2003","unstructured":"Werdenberga D, Joshib R, Wolfframc S, Merklea HP, Langguthd P. Presystemic metabolism and intestinal absorption of antipsoriatic fumaric acid esters. Biopharm Drug Dispos. 2003;24:259\u201373.","journal-title":"Biopharm Drug Dispos"}],"container-title":["European Journal of Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-015-0311-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13318-015-0311-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-015-0311-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-015-0311-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T21:56:21Z","timestamp":1567374981000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13318-015-0311-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,30]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["311"],"URL":"https:\/\/doi.org\/10.1007\/s13318-015-0311-4","relation":{},"ISSN":["0378-7966","2107-0180"],"issn-type":[{"value":"0378-7966","type":"print"},{"value":"2107-0180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,30]]}}}